Reticulocyte Hemoglobin Equivalent (RET-He) In The Management Of Pre-operative Anemia: Is It Useful Information? A Pilot Study. By: Donna Touchie
GATA3 Expression Profile in Invasive Breast Carcinoma Post Neo-Adjuvant Systemic Chemotherapy. By: Phillip A. Williams MD MSc
Mean Platelet Volume and Immature Granulocyte Count in ICU Sepsis Patients and Disposition at 30 days. By: Vito Sanci
Pseudo-Outbreak of Mycobacterium fortuitum Due to Contaminated Ice Machines.
By: N. Sant
Resident-led Autopsy Teaching and Autopsy Quality Improvement at The Ottawa Hospital. By: S.Strickland
Role Of Fine-needle Aspiration In The Surgical Management Of Pancreatic Neuroendocrine Tumors Utility and Limitations in Light of the New WHO Classification. By: Shaheed W.
Pathological Phenotype of Uterine Leiomyomas from Patients With Hereditary Leiomyomatosis and Renal Cell Cancer (HLRCC) Syndrome. By: S. Strickland
Novel Technique of Sampling the Urinary Bladder for Urothelial Carcinoma Specimens. By: Christopher G. Ball
An Explanation for Pathological Utero-Placental Blood Flow in Placenta Crete. By: Christopher G. Ball
Basal-like variant of non-invasive urothelial carcinoma: A variant of urothelial carcinoma with immunohistochemical features of basal-like urothelial cells associated with high rate of recurrence and invasion. By: Christopher G. Ball
Basal-like variant of non-invasive urothelial carcinoma A variant of urothelial carcinoma with immunohistochemical features of basal-like urothelial cells associated with high rate of recurrence and invasion
Boundary Conditions for Three Placental Flow Fields That May Predict and Cause Intra-Uterine Growth Retardation. By: Christopher G. Ball
Porous media flow models for maternal placental circulation. By: Christopher G. Ball
Lab Medicine Prepares for a New Era Why Healthcare’s Evolution Creates new Roles for Clinical Labs
Positioning the Laboratory to Integrate Clinical Care New Approaches to Interactive Test Ordering and Test Reporting
Preparing for Precision Medicine Lessons in the Transformation of Anatomic Pathology at Henry Ford Health
Roche Personalised Healthcare – In Brief
The future of Pathology – EORLA
The Ontario Laboratories Information System (OLIS) enables hospitals, community laboratories, public health labs and physicians to securely exchange lab test results.
There are many benefits:
- Timely and complete up-to-date lab information for your care team
- Less duplication of lab tests
- Fewer gaps in patient information between the hospital and your family physician
- If you wish to restrict access to your information on OLIS, please contact Service Ontario at 1-800-291-1405 (TTY 1-800-387-5559)
Broader Public Sector Accountability Act (BPSAA) Attestation
In the spirit of public disclosure, EORLA has posted our Attestation signed by the CEO and Board Chair, prepared in accordance with section 15 of the Broader Public Sector Accountability Act, 2010 (BPSAA). TOH is in compliance with all the directives under this act.